How to buy PAVmed stock | $1.76

PAVmed Inc is a medical devices business based in the US. PAVmed shares (PAVM) are listed on the NASDAQ and all prices are listed in US Dollars. PAVmed employs 15 staff and has a market cap (total outstanding shares value) of USD$110.1 million.

How to buy shares in PAVmed

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for PAVmed. Find the stock by name or ticker symbol: PAVM. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until PAVmed reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$1.76, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of PAVmed, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of PAVmed. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

PAVmed share price

Use our graph to track the performance of PAVM stocks over time.

PAVmed shares at a glance

• Key figures

Information last updated 2020-12-30.

Latest market close	USD$1.76
52-week range	USD$1.14 - USD$3.45
50-day moving average	USD$1.8944
200-day moving average	USD$1.9639
Wall St. target price	USD$5.08
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-0.647

Buy PAVmed shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy PAVmed stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of PAVmed Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

PAVmed price performance over time

Historical closes compared with the close of $1.76 from 2020-12-18

1 week (2021-01-08)	-17.37%
1 month (2020-12-16)	-8.33%
3 months (2020-10-15)	-11.56%
6 months (2020-07-15)	-15.79%

1 year (2020-01-15)	28.47%
2 years (2019-01-15)	83.33%
3 years (2018-01-12)	2.96
5 years (2016-01-12)	N/A

PAVmed financials

Gross profit TTM	USD$0
Return on assets TTM	-170.89%
Return on equity TTM	0%
Profit margin	0%
Book value	$-0.108
Market capitalisation	USD$110.1 million

TTM: trailing 12 months

Shorting PAVmed shares

There are currently 3.7 million PAVmed shares held short by investors – that's known as PAVmed's "short interest". This figure is 15.7% up from 3.2 million last month.

There are a few different ways that this level of interest in shorting PAVmed shares can be evaluated.

PAVmed's "short interest ratio" (SIR)

PAVmed's "short interest ratio" (SIR) is the quantity of PAVmed shares currently shorted divided by the average quantity of PAVmed shares traded daily (recently around 1.4 million). PAVmed's SIR currently stands at 2.67. In other words for every 100,000 PAVmed shares traded daily on the market, roughly 2670 shares are currently held short.

However PAVmed's short interest can also be evaluated against the total number of PAVmed shares, or, against the total number of tradable PAVmed shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case PAVmed's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 PAVmed shares in existence, roughly 60 shares are currently held short) or 0.0738% of the tradable shares (for every 100,000 tradable PAVmed shares, roughly 74 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against PAVmed.

Find out more about how you can short PAVmed stock.

PAVmed share dividends

We're not expecting PAVmed to pay a dividend over the next 12 months.

PAVmed share price volatility

Over the last 12 months, PAVmed's shares have ranged in value from as little as $1.14 up to $3.45. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while PAVmed's is 0.1132. This would suggest that PAVmed's shares are less volatile than average (for this exchange).

PAVmed overview

PAVmed Inc. operates as a medical device company in the United States. The company's lead product pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; EsoCheck, an non-invasive cell collection device and DNA biomarkers to detect esophageal cancer precursor; PortIO, an implantable intraosseous vascular access device; and DisappEAR, an antimicrobial resorbable ear tube. Its product pipeline also comprises NextCath, a self-anchoring catheter; NextFlo, a disposable infusion system; and Caldus, a disposable tissue ablation device. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was founded in 2014 and is based in New York, New York.

Frequently asked questions

• What percentage of PAVmed is owned by insiders or institutions?

  Currently 16.103% of PAVmed shares are held by insiders and 10.832% by institutions.

• How many people work for PAVmed?

  Latest data suggests 15 work at PAVmed.

• When does the fiscal year end for PAVmed?

  PAVmed's fiscal year ends in December.

• Where is PAVmed based?

  PAVmed's address is: One Grand Central Place, New York, NY, United States, 10165

• What is PAVmed's ISIN number?

  PAVmed's international securities identification number is: US70387R1068

• What is PAVmed's CUSIP number?

  PAVmed's Committee on Uniform Securities Identification Procedures number is: 70387R106